JD Supra: Mergers

FEBRUARY 28, 2024

Traditionally, private equity firms were seen as benign investors from an antitrust perspective. This is changing. In the past 12 months, PE-funded acquisitions have faced progressively more rigorous scrutiny by antitrust authorities. By: Allen & Overy LLP

Private Equity 190

Private Equity Equities Funds Investors 190

JD Supra: Mergers

JUNE 12, 2024

Episode 7: Exploring the Role of Operating Partners in Private Equity In this episode of BRight Minds in Healthcare Delivery, Donna Cooper joins host Eric Tower for a conversation about her career and how her prior experience has influenced her current role as an operating partner. Donna explains the role of an operating partner at….

Private Equity 163

Private Equity Equities Healthcare 163

JD Supra: Mergers

MAY 22, 2024

McGuireWoods recently held its 20th Annual Healthcare Private Equity and Finance Conference (HCPE Conference) in Chicago. The conference drew more than 1,000 professionals from private equity funds, senior and mezzanine lenders, and investment banks, as well as C-level executives, consultants and principals in the healthcare industry.

Private Equity 163

Private Equity Healthcare Finance Finance 163

Deal Lawyers

JULY 12, 2024

The fourth quarter of 2023 saw an uptick in global M&A activity that’s continued through the second quarter of 2024, but until recently, Private Equity didn’t appear to participate in the rebound. According to a new PitchBook report on PE deal activity, that started to change in the second quarter.

Private Equity 100

Private Equity Equities M&A 100

JD Supra: Mergers

JANUARY 9, 2024

As we begin 2024, we have highlighted the issues and trends that private equity (PE) investors should consider when evaluating transactions in the healthcare sector. W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity.

Private Equity 198

Private Equity Healthcare Equities Funds 198

JD Supra: Mergers

MAY 21, 2024

What do private equity and growth capital investors look for when adding new companies to their portfolio, and what strategies do they apply to help those companies optimize capital? They covered the current private equity landscape, strategies for creating value, industry trends, various investment structures, and more.

Private Equity 169

Private Equity Equities Capital Mergers and Acquisitions 169

JD Supra: Mergers

MAY 17, 2024

a federal district court granted private equity firm Welsh, Carson, Anderson & Stowe's motion to dismiss it from the Federal Trade Commission's (FTC) lawsuit alleging an anticompetitive scheme to drive up the price of anesthesia services by orchestrating a decade-long "roll-up" strategy to consolidate anesthesiology practices in Texas.

Private Equity 175

Private Equity Equities Trading IT 175

Deal Lawyers

JUNE 17, 2024

Woodruff Sawyer recently issued its “Guide to Insuring Fund Liability Risks for Venture Capital and Private Equity Firms.” ” The publication provides an overview of the key coverages and claims scenarios.

Private Equity 112

Private Equity Insurance Equities Funds 112

JD Supra: Mergers

MARCH 8, 2024

Private equity is squarely in the cross hairs of regulators; the Department of Justice Antitrust Division, the Federal Trade Commission, and the U.S. Department of Health and Human Services recently announced the launch of a joint inquiry into private equity ownership in the health care field. By: Ballard Spahr LLP

Private Equity 190

Private Equity Equities Acquisitions Trading 190

JD Supra: Mergers

MAY 28, 2024

The UK Takeover Panel (the Panel) has published a new framework for private sale processes. If you are a private equity investor considering potential P2P acquisitions after receiving initial soundings from management teams, then this new regime should be helpful in enabling early stage talks to happen in private.

Private Equity 169

Private Equity Sale Investors Equities 169

JD Supra: Mergers

MARCH 12, 2024

Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. By: Mayer Brown

Private Equity 180

Private Equity Healthcare Equities Acquisitions 180

JD Supra: Mergers

MARCH 12, 2024

On March 5, the FTC convened a workshop with regulators, academics and stakeholders to discuss the impact of private equity in the healthcare market. The workshop reflects the FTC and DOJ Antitrust Division’s recent focus on private equity and serial roll-up transactions more broadly as targets for antitrust enforcement.

Private Equity 169

Private Equity Healthcare Equities Acquisitions 169

JD Supra: Mergers

MAY 30, 2024

The Federal Trade Commission’s (FTC) push against private equity roll-ups has hit a snag. Judge Hoyt found that the FTC had not adequately alleged that Welsh Carson “is violating” or “is about to violate” antitrust laws, as required under.

Private Equity 185

Private Equity Equities Trading 185

JD Supra: Mergers

APRIL 1, 2024

The California legislature is considering a bill that could severely impact the ability for private equity companies and hedge funds to operate in the California health care industry. By: Polsinelli

Private Equity 180

Private Equity Equities Funds Investment 180

JD Supra: Mergers

JUNE 12, 2024

Department of Health and Human Services’ (together the “Agencies”) request for information regarding consolidation in healthcare by private equity. Department of Justice, and the U.S. By: Sheppard Mullin Richter & Hampton LLP

Private Equity 169

Private Equity Healthcare Equities Trading 169

JD Supra: Mergers

MARCH 8, 2024

A recent government initiative announced on March 5, 2024 signals that more antitrust scrutiny for private equity firms and asset managers is on the horizon. By: Paul Hastings LLP

Private Equity 163

Private Equity Equities Healthcare Asset Management 163

JD Supra: Mergers

MARCH 8, 2024

On March 5, the Federal Trade Commission (FTC) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care.” The event is part of the agency’s effort to publicize and encourage enforcement targeting private equity investments in health care.

Private Equity 185

Private Equity Equities Trading Capital 185

JD Supra: Mergers

APRIL 22, 2024

A recently introduced California Assembly Bill (AB 3129), targeting private equity (PE) physician practice investments, is currently making its way through the legislative process.

Private Equity 175

Private Equity Equities Investment Acquisitions 175

JD Supra: Mergers

MAY 22, 2024

On 13 May, a federal district court judge dismissed the Federal Trade Commission’s (FTC) antitrust case against private equity firm Welsh, Carson, Anderson & Stowe and affiliated entities (Welsh Carson). The FTC’s case alleged that Welsh Carson, along with its portfolio company, US Anesthesia Partners, Inc.

Private Equity 163

Private Equity Equities Portfolio Trading 163

JD Supra: Mergers

SEPTEMBER 25, 2023

USAP”), and the private equity firm Welsh, Carson, Anderson & Stowe (“Welsh Carson”), which created USAP, executed a multi-year anticompetitive scheme to consolidate anesthesiology practices in Texas, drive up the price of anesthesia services provided to Texas patients and boost their own profits. Anesthesia Partners, Inc.

Private Equity 286

Private Equity Equities Profitability Trading 286

JD Supra: Mergers

MARCH 13, 2024

Private equity investment in the health care sector continues to be a significant area of focus for the U.S. On March 5, 2024, the Federal Trade Commission (FTC) hosted a public workshop to “examine the role of private equity investment in health care markets” (the FTC workshop). antitrust agencies.

Private Equity 157

Private Equity Equities Investment Trading 157

JD Supra: Mergers

MAY 29, 2024

In a decision with significant implications for private equity firms and minority investors, on May 13, 2024, the US District Court for the Southern District of Texas dismissed the Federal Trade Commission’s (FTC) suit against a fund of private equity firm Welsh, Carson, Anderson & Stowe (Welsh Carson) that is a minority investor in US Anesthesia (..)

Private Equity 169

Private Equity Equities Investors Funds 169

OfficeHours

AUGUST 9, 2023

To know if the buyside is right for you, let’s start with a textbook understanding of “What is private equity?” Private equity involves investing capital directly into private businesses that are not publicly traded on stock exchanges (that would be a hedge fund). Strategic thinking skills are essential.

Private Equity 130

Private Equity Equities Investment Banking Finance 130

JD Supra: Mergers

MAY 21, 2024

On May 13, a federal district court in Texas dismissed private equity firm Welsh, Carson, Anderson & Stowe (Welsh Carson) from an antitrust lawsuit filed by the Federal Trade Commission (FTC). The lawsuit, which was originally filed in 2023, alleged that Welsh Carson and co-defendant U.S. Anesthesia Partners, Inc.

Private Equity 169

Private Equity Equities Trading 169

JD Supra: Mergers

MAY 24, 2024

While much of the conversation has naturally focused on the rule’s significant impact on employees and how it will invalidate existing non-competes for millions of workers, the FTC’s actions will also have key ramifications for M&A and private equity transactions across all industries. By: Mintz - Employment Viewpoints

Private Equity 185

Private Equity M&A Equities Trading 185

Deal Lawyers

MARCH 18, 2024

In early March, the FTC, DOJ & HHS announced a “cross-government public inquiry into private equity and other corporations’ increasing control over health care.”

Private Equity 112

Private Equity Healthcare Equities Acquisitions 112

OfficeHours

JUNE 6, 2023

Private equity is an investment asset class that has gained significant prominence and popularity in recent decades. However, private equity can seem complex and intimidating to beginners who are unfamiliar with its fundamentals. Private equity firms also invest in distressed debt or provide private debt financing.

Private Equity 147

Private Equity Equities Debt Investors 147

JD Supra: Mergers

JUNE 3, 2024

California’s AB 3219, which would require private equity firms and hedge funds to obtain prior approval to consummate certain healthcare-related transactions, is now one step closer to becoming law following the State Assembly’s May 22, 2024 passage of the pending legislation.

Private Equity 169

Private Equity Healthcare Equities Funds 169

The New York Times: Mergers, Acquisitions and Dive

MARCH 18, 2024

Private equity is cannibalizing the music industry by buying up old hits and pushing them back into our cultural consciousness.

Private Equity 137

Private Equity Equities Mergers and Acquisitions Funds 137

Deal Lawyers

MAY 7, 2024

That’s why this CLS Blue Sky Blog discussing a new article on the history of private equity caught my eye. If you’ve been reading this blog for a while, you know I’ve got a soft spot for M&A history. The blog says that although most M&A professionals would probably say that PE really began in […]

Private Equity 131

Private Equity Equities IT M&A 131

OfficeHours

JUNE 2, 2023

When you first decide to enter the world of private equity, you will undoubtedly be more overwhelmed than you were when you entered investment banking recruiting. Below, I will outline some of the best private equity firms to work for in 2023. And with the firm recently closing a new $3.25

Private Equity 147

Private Equity Equities Middle Market Funds 147

OfficeHours

JUNE 5, 2023

Private equity consulting firms play a crucial role in the success of portfolio companies by providing specialized expertise and strategic guidance. Private equity consulting firms go beyond traditional advisory services by providing value-added services to their clients.

Private Equity 147

Private Equity Consulting Portfolio Equities 147

JD Supra: Mergers

MAY 17, 2024

Anesthesia Partners (USAP) and Welsh Carson, a private equity fund that owns 23 percent of USAP and controls two of 14 board seats, engaged in an anticompetitive scheme to acquire and consolidate anesthesia practices in Texas partially survived motions to dismiss by the two defendants. The Federal Trade Commission’s suit alleging U.S.

Private Equity 169

Private Equity Equities Trading Funds 169

OfficeHours

JUNE 5, 2023

Private equity firms play a vital role in the broader investment landscape, and their success relies heavily on their ability to execute deals effectively. Simply put, any private equity associate course must focus on developing and refining these skills.

Private Equity 147

Private Equity Equities Financial Modeling Financial Models 147

OfficeHours

JUNE 12, 2023

Working in private equity is highly attractive for many reasons, and many finance professionals who are not already in the field often look for ways to break in. One of the primary ways to do so is by landing an internship at a private equity firm you might want to work at.

Private Equity 147

Private Equity Equities Investment Valuation 147

JD Supra: Mergers

JULY 19, 2023

Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—private equity firms have a lot of capital to put to work. One area receiving interest is the ear, nose, and throat (ENT) and allergy field. By: FOCUS Investment Banking

Private Equity 130

Private Equity Equities Investment Banking Healthcare 130

JD Supra: Mergers

OCTOBER 17, 2023

USAP”) and its private equity sponsor, Welsh, Carson, Anderson & Stowe (“Welsh Carson”) alleging an anticompetitive scheme to consolidate anesthesiology practices in Texas through a series of systematic roll-ups; price setting arrangements; and a market allocation agreement to dominate the anesthesia market in Texas.

Private Equity 274

Private Equity Equities Acquisitions Trading 274